相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
Susan Manzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Immunologic characteristics of intrarenal T cells: Trafficking of expanded CD8+ T cell β-chain clonotypes in progressive lupus nephritis
Robert Winchester et al.
ARTHRITIS AND RHEUMATISM (2012)
Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages
Takeshi Kadowaki et al.
CLINICAL IMMUNOLOGY (2012)
Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner
Souichi Oomizu et al.
CLINICAL IMMUNOLOGY (2012)
Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes
Motoko Kanzaki et al.
ENDOCRINOLOGY (2012)
Underexpression of TIM-3 and Blunted Galectin-9-Induced Apoptosis of CD4+T Cells in Rheumatoid Arthritis
Jaejoon Lee et al.
INFLAMMATION (2012)
The Rationale for BAFF Inhibition in Systemic Lupus Erythematosus
Anne Davidson
CURRENT RHEUMATOLOGY REPORTS (2012)
Oral Administration of Artemisinin Analog SM934 Ameliorates Lupus Syndromes in MRL/lpr Mice by Inhibiting Th1 and Th17 Cell Responses
Li-Fei Hou et al.
ARTHRITIS AND RHEUMATISM (2011)
Tim-3 ligand galectin-9 reduces IL-17 level and accelerates Klebsiella pneumoniae infection
Feng Wang et al.
CELLULAR IMMUNOLOGY (2011)
Lupus Nephritis in Colombians: Contrasts and Comparisons with Other Populations
Juan-Manuel Anaya et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis
Kazuki Sakai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
BAFF inhibition: A new class of drugs for the treatment of autoimmunity
Zheng Liu et al.
EXPERIMENTAL CELL RESEARCH (2011)
Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus
Weronika Kleczynska et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2011)
Influence of Galectin-9/Tim-3 Interaction on Herpes Simplex Virus-1 Latency
Pradeep B. J. Reddy et al.
JOURNAL OF IMMUNOLOGY (2011)
BAFF and selection of autoreactive B cells
Zheng Liu et al.
TRENDS IN IMMUNOLOGY (2011)
Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation
Tomohiro Arikawa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
TIM-3 as a new therapeutic target in systemic lupus erythematosus
Hai-Feng Pan et al.
MOLECULAR BIOLOGY REPORTS (2010)
Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus
Kamini Shah et al.
ARTHRITIS RESEARCH & THERAPY (2010)
B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin
Stacey R. Dillon et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+ T Cell Response
Sharvan Sehrawat et al.
PLOS PATHOGENS (2010)
Th17 and Natural Treg Cell Population Dynamics in Systemic Lupus Erythematosus
Ji Yang et al.
ARTHRITIS AND RHEUMATISM (2009)
Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris
Angela Nagel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
Elodie Belnoue et al.
BLOOD (2008)
Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
Masako Seki et al.
CLINICAL IMMUNOLOGY (2008)
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients
Y. Wang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus
Maria Dall'Era et al.
ARTHRITIS AND RHEUMATISM (2007)
The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft
Feng Wang et al.
CELLULAR IMMUNOLOGY (2007)
In vitro and in vivo activation induces BAFF and APRIL expression in B cells
Van Trung Chu et al.
JOURNAL OF IMMUNOLOGY (2007)
Raised serum APRIL levels in patients with systemic lupus erythematosus
T Koyama et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Development of highly stable galectins: Truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins
N Nishi et al.
FEBS LETTERS (2005)
IFN-α induces early lethal lupus in preautoimmune (New Zealand black x New Zealand White)F1 but not in BALB/c mice
A Mathian et al.
JOURNAL OF IMMUNOLOGY (2005)
Autoimmune disease complicating antiviral therapy for hepatitis C virus infection
LE Wilson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Drug-induced systemic lupus erythematosus and TNF-α blockers
AK Mohan et al.
LANCET (2002)
Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats
Y Tsuchiyama et al.
KIDNEY INTERNATIONAL (2000)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
分享论文
